|
|
Today is the first day of the subscription period in SciBase rights issue |
|
|
SciBase publishes prospectus in connection with upcoming rights issue |
|
|
Notice to extraordinary general meeting in Scibase Holding AB (publ) |
|
|
SciBase resolves on a directed issued of approximately SEK 33 million and a rights issue of approximately SEK 15 million |
|
|
SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform |
|
|
Year-end report |
|
|
Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami |
|
|
New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL |
|
|
SciBase initiates collaboration with Inderes for commissioned research |
|
|
Welcome to SciBase Capital Markets Day 2024 |
